Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-05-15 3:27 pm Purchase | 2025-03-31 | 13G | FibroGen, Inc. FGEN | Armistice Capital, LLC | 340,000 8.420% | 68,000 (+25.00%) | Filing History |
| 2025-02-14 5:49 pm Unchanged | 2024-12-31 | 13G | FibroGen, Inc. FGEN | Armistice Capital, LLC | 272,000 6.750% | 0 (Unchanged) | Filing History |
| 2025-02-13 6:24 pm Sale | 2024-12-31 | 13G | FibroGen, Inc. FGEN | PRIMECAP MANAGEMENT CO/CA/ | 184,645 4.580% | -211,804 (-53.43%) | Filing History |
| 2024-11-14 4:52 pm Sale | 2024-09-30 | 13G | FibroGen, Inc. FGEN | Armistice Capital, LLC | 272,000 6.770% | -118,560 (-30.36%) | Filing History |
| 2024-11-12 4:01 pm Sale | 2024-09-30 | 13G | FibroGen, Inc. FGEN | PRIMECAP MANAGEMENT CO/CA/ | 396,449 9.870% | -182,428 (-31.51%) | Filing History |
| 2024-11-12 2:33 pm Unchanged | 2024-09-30 | 13G | FibroGen, Inc. FGEN | The Vanguard Group | 235,294 5.850% | 0 (Unchanged) | Filing History |
| 2024-11-04 1:08 pm Unchanged | 2024-09-30 | 13G | FibroGen, Inc. FGEN | The Vanguard Group | 235,294 5.850% | 0 (Unchanged) | Filing History |
| 2024-11-04 12:11 pm Sale | 2024-09-30 | 13G | FibroGen, Inc. FGEN | The Vanguard Group | 235,294 5.850% | -46,472 (-16.49%) | Filing History |
| 2024-07-08 4:32 pm Sale | 2024-06-30 | 13G | FibroGen, Inc. FGEN | BlackRock Inc. BLK | 96,386 2.400% | -191,826 (-66.56%) | Filing History |
| 2024-02-14 3:37 pm Purchase | 2023-12-31 | 13G | FibroGen, Inc. FGEN | Armistice Capital, LLC | 390,560 9.930% | 390,560 (New Position) | Filing History |
| 2024-02-14 10:04 am Sale | 2023-12-31 | 13G | FibroGen, Inc. FGEN | Point72 Asset Management, L.P. | 65,754 1.700% | -185,512 (-73.83%) | Filing History |
| 2024-02-13 5:04 pm Sale | 2023-12-29 | 13G | FibroGen, Inc. FGEN | The Vanguard Group | 281,766 7.160% | -95,997 (-25.41%) | Filing History |
| 2024-02-12 4:01 pm Purchase | 2023-12-31 | 13G | FibroGen, Inc. FGEN | PRIMECAP MANAGEMENT CO/CA/ | 578,877 14.720% | 23,074 (+4.15%) | Filing History |
| 2024-01-26 4:23 pm Purchase | 2023-12-31 | 13G | FibroGen, Inc. FGEN | BlackRock Inc. BLK | 288,212 7.300% | 2,862 (+1.00%) | Filing History |
| 2023-07-19 4:47 pm Purchase | 2023-07-13 | 13G | FibroGen, Inc. FGEN | Millennium Management LLC | 183,513 4.700% | 183,513 (New Position) | Filing History |
| 2023-02-14 4:22 pm Purchase | 2022-12-31 | 13G | FibroGen, Inc. FGEN | Point72 Asset Management, L.P. | 251,266 6.700% | 64,622 (+34.62%) | Filing History |
| 2023-02-09 4:01 pm Purchase | 2022-12-31 | 13G | FibroGen, Inc. FGEN | PRIMECAP MANAGEMENT CO/CA/ | 555,803 14.790% | 36,238 (+6.97%) | Filing History |
| 2023-02-09 11:19 am Purchase | 2022-12-30 | 13G | FibroGen, Inc. FGEN | The Vanguard Group | 377,763 10.050% | 2,355 (+0.63%) | Filing History |
| 2023-02-08 10:05 am Sale | 2022-12-31 | 13G | FibroGen, Inc. FGEN | First Trust Portfolios L.P. | 119,026 3.170% | -93,678 (-44.04%) | Filing History |
| 2023-02-06 12:37 pm Purchase | 2022-12-31 | 13G | FibroGen, Inc. FGEN | BlackRock Inc. BLK | 285,350 7.600% | 19,528 (+7.35%) | Filing History |